We are delighted to announce that RGCC has received prestigious recognition as one of the top 10 Swiss Biotech companies in 2023 by Life Sciences Review.

Proudly standing alongside Switzerland's esteemed biotech leaders, this acknowledgment underscores our unwavering commitment to innovation, excellence, and our continual contribution to the life sciences sector. It also reflects our dedication to pushing the boundaries of innovation and making a positive impact in the dynamic field of life sciences.

Explore further details about the award and delve into the comprehensive profile provided by Life Sciences Review by clicking here.